Trade FDMT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
4D Molecular Therapeutics, Inc. (FDMT) is trading at US$15.88, up 4.20% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$874.52M. Over the past 52 weeks, FDMT has traded between US$6.96 and US$16.93. On Syfe you can trade FDMT with $0 commission and add it to your watchlist.
| Previous close | US$15.24 |
|---|---|
| Market cap | US$874.52M |
| 52-week range | US$6.96 – US$16.93 |
| Volume | 936.58K |
| Exchange | US |
Add to Watchlist
Set Price Alert
4D Molecular Therapeutics, Inc.
4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. The company combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine creates a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.
Year: 2020
B. Riley Initiates 4D Molecular Therapeutics at Buy With $37 Price Target
Jul 31, 1:33 PM · MT Newswires
4D Molecular Therapeutics Completes Enrollment in Phase 3 Wet AMD Trial
Jun 29, 12:43 PM · MT Newswires
4D Molecular Therapeutics, Inc. (FDMT) stock is trading at US$15.88, +4.20% from the previous close of US$15.24.
The market cap for 4D Molecular Therapeutics, Inc. (FDMT) stock is approximately US$874.52M.
The 52-week high for 4D Molecular Therapeutics, Inc. (FDMT) stock is US$16.93.
The 52-week low for 4D Molecular Therapeutics, Inc. (FDMT) stock is US$6.96.
4D Molecular Therapeutics, Inc. (FDMT) does not currently pay a dividend.
Stay on top of FDMT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
